At a glance
- Originator Servier
- Class Anxiolytics
- Mechanism of Action 5-HT1A serotonin receptor agonists; Serotonin 2A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Anxiety disorders
Most Recent Events
- 02 Sep 1998 No-Development-Reported for Anxiety disorders in France (Unknown route)
- 15 Feb 1996 New profile
- 15 Feb 1996 Preclinical development for Anxiety disorders in France (Unknown route)